MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Janux Therapeutics (JANX) Ownership - Who owns Janux Therapeutics?

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

Profile

Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.08B
P/E Ratio
-10.75
Total Cash
970.91M
Projected Growth
N/A
Total Debt
20.99M
Revenue
24M
Risk (Beta)
4.19
Dividend Yield
N/A
Total Cash/Share
15.88
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Who owns Janux Therapeutics? JANX symbol Ownership - Tickeron.com